Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
MBL · Predicate Candidate Screening
13 FDA 510(k) clearances under this product code; the 50 most recent screened below.
90 daysmedian FDA review time
390 days90th percentile
13clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K201157 | Prime BIOFOAM® Multi-Hole Shells | Microport Orthopedics, Inc. | 2021-08-24 | 481 | 0 |
| K201701 | R3 HA Coated Acetabular Shells | Smith & Nephew, Inc. | 2020-10-06 | 106 | 0 |
| K182535 | R3 Anteverted Liners | Smith & Nephew, Inc. | 2018-11-19 | 66 | 0 |
| K161233 | OXINIUM DH Fermoral Heads | Smith & Nephew, Inc. | 2016-12-14 | 226 | 0 |
| K122382 | DYNASTY BIOFOAM SHELL | Wrightmedicaltechnologyinc | 2012-10-22 | 77 | 0 |
| K113848 | R3 XLPE LINERS | Smith & Nephew, Inc. | 2012-04-27 | 120 | 2 |
| K102370 | R3 XLPE ANTEVERTED LINERS | Smith & Nephew, Inc. | 2011-01-19 | 152 | 0 |
| K093363 | COCR AND OXINIUM FEMORAL HEADS AND R3 XLPE LINERS | Smith & Nephew, Inc. | 2010-01-26 | 90 | 0 |
| K092386 | R3 MULTI-HOLE SHELLS AND 36MM XLPE ACETABULAR LINERS | Smith & Nephew, Inc. | 2009-11-03 | 90 | 0 |
| K070756 | SMITH AND NEPHEW REFLECTION 3 ACETABULAR SYSTEM | Smith & Nephew, Inc. | 2007-06-06 | 78 | 0 |
| K061253 | REFLECTION 3 ACETABULAR SYSTEM | Smith & Nephew, Inc. | 2006-05-31 | 27 | 0 |
| K960094 | REFLECTION DUAL DIMENSION SHELL | Smith & Nephew Richards, Inc. | 1996-03-27 | 76 | 1 |
| K931107 | LOGYK ACETABULAR COMPONENT SYSTEM | Arthronics, Inc. | 1994-03-28 | 390 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda